Utilisation of Angiox® in European Practice (EURO-vision)

The Medicines Company

Status: Completed

Conditions: Stable Angina (SA); NSTE-ACS (NSTEMI and UA); STEMI (STE-ACS)

Study type: Observational

Funder types: Industry

Identifiers

NCT01011504

TMC-BIV-08-02

Details and patient eligibility

About

The objective of this study is to determine utilisation patterns in patients receiving Angiox® in participating European centres. Additionally, through the collection of descriptive safety and outcomes data, this study will contribute to the Risk Management strategy for Europe

Enrollment: 2,019 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Eligible for, and receive treatment with Angiox®.
• Willing and able to provide written informed consent to the use of their data in accordance with relevant local Data Protection laws, policies and regulations

Exclusion criteria

• Participation in other interventional clinical research studies involving the evaluation of investigational drugs, including Angiox®, or devices at the time of enrolment.
• Patients not eligible for treatment for Angiox®.